700 patients110,866 observations180 daysLIVE

Patient P-02210

Synthetic patientMETA-24 · Day 169 · 55–64 · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
23%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S14

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • GI instability-16
  • Nutritional resilience+9
  • Inflammatory activity-7
  • Toxicity+4

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    45 min
    stable · -1.6 vs previous 14 d
    Sleep duration
    Wearable
    5.9 h
    stable · +0.2 vs previous 14 d
    Energy level
    Daily log
    5.6/10
    stable · -0.0 vs previous 14 d
    Steps
    Wearable
    5,546
    worsening · -516 vs previous 14 d
    GI burden
    Companion
    14.3/100
    improving · -5.3 vs previous 14 d
    Adherence
    Companion
    91 %
    stable · +2.1 vs previous 14 d
    Sleep quality
    Wearable
    32.2/100
    improving · +6.0 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    138 mg/dL
    stable · -1.5 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 79 from the failing basin, 15 from restoration.

    Good elements to keep
    • Butyrate producers intact
      hidden · steering +7.5
    • Protein (supports)
      perturbation · steering +6.6
    • Dietary fat load (supports)
      perturbation · steering +4.4
    • Daily walks resumed
      perturbation · steering +3.3
    • Protein
      supporter · GI -4.3 next day
    • Dietary fat load
      supporter · GI -2.5 next day
    Main detractors to watch
    • Poor metabolizer
      hidden · steering -12.7
    • Low microbial diversity
      hidden · steering -7.7
    • Ultra-processed food
      perturbation · steering -7.7
    • IL6 high-expression variant
      hidden · steering -7.3
    • Ultra-processed food
      detractor · GI +4.2 next day
    • Simple carbohydrates
      detractor · GI +3.8 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -4.3supporter · 95%
    • Ultra-processed food
      +4.2detractor · 95%
    • Simple carbohydrates
      +3.8detractor · 95%
    • Caffeine
      +3.8detractor · 95%
    • Alcohol
      +3.6detractor · 95%
    • Histamine load
      +2.7detractor · 82%
    • Dietary fat load
      -2.5supporter · 76%
    • Insoluble fibre
      +0.5no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Autonomic recovery 45
      • WearableResting HR 73 bpm
      • WearableShort sleep window
    • Drug metabolism and exposure 40
      • DNACYP2D6 poor metabolizer → higher exposure
    • Inflammatory signalling 25
      • DNAIL6 -174 variant raises baseline inflammatory tone
    • Butyrate / short-chain fatty acid production 25
      • MicrobiomeF. prausnitzii depleted
    • Mucosal barrier integrity 10
      • WearableSleep 5.9 h, below personal baseline
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Poor metabolizer
      Higher exposure at standard dose
    Microbiome
    Shannon diversity 2.8 · butyrate capacity 58/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    41 ms
    Sleep
    6.0 h
    Steps
    5,576
    Resting HR
    76 bpm
    Daily log: GI score 14, nutritional resilience 67, adherence 91.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0221749%S0161
    P-0255048%S0170
    P-0262048%S01HY-01improved64
    P-0243746%S0164
    P-0256845%S0151
    P-0227643%S0157
    P-0268143%S0151
    P-0230742%S0155
    P-0259841%S0153
    P-0235440%S01CR-01improved78
    P-0221839%S01DT-01improved61
    P-0242439%S0162